GP
ILMN icon

Geneva Partners’s Illumina ILMN Stock Holding History

Geneva Partners’s Portfolio ILMN Stock Details ILMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-771
Closed -$288K – 98
2021
Q1 		$288K Buy
+771
New +$314K 0.15% 75
2019
Q1 		– Sell
-1,244
Closed -$363K – 69
2018
Q4 		$363K Sell
1,244
-6,723
-84% -$2.08M 0.42% 47
2018
Q3 		$2.85M Buy
7,967
+2,454
+45% +$786K 2.19% 17
2018
Q2 		$1.5M Buy
5,513
+3,529
+178% +$898K 1.19% 30
2018
Q1 		$456K Buy
+1,984
New +$455K 0.37% 63

Other funds holding ILMN

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Geneva Partners's ILMN Position: Q2 2021 in Review

Geneva Partners sold out of Illumina (ILMN) in Q2 2021, closing a stake of 771 shares — an estimated $288K sold.

Geneva Partners first reported a position in ILMN in Q1 2018 and held it in 5 quarters. The position peaked at $2.85M in Q3 2018. 1,068 funds tracked by Wall St. Rank hold ILMN as of Q2 2021.

  • Geneva Partners reported no remaining Illumina position as of Q2 2021 after selling out during the quarter.
  • Geneva Partners sold 771 Illumina shares in Q2 2021, an estimated $288K.
  • Geneva Partners first reported a position in Illumina in Q1 2018 and held it in 5 quarters.
  • Geneva Partners's Illumina position peaked at $2.85M in Q3 2018.
  • 1,068 funds tracked by Wall St. Rank held Illumina as of Q2 2021.

Based on Geneva Partners's 13F filing for Q2 2021, filed 6 Aug 2021.